Kiran Musunuru, MD, PhD, MPH

HSCI Alumni: Kiran Musunuru, MD, PhD, MPH

Harvard Department of Stem Cell and Regenerative Biology
Brigham and Women's Hospital
The Broad Institute

Our goal is to understand how naturally occurring human genetic variation protects (or predisposes) some people to cardiovascular and metabolic disease—the leading cause of death in the world—and to use that information to develop therapies that can protect the entire population from disease.... Read more about Kiran Musunuru, MD, PhD, MPH

John Quackenbush, PhD

HSCI Alumni: John Quackenbush, PhD

Harvard School of Public Health
Dana-Farber Cancer Institute

Our research group focuses on methods spanning the laboratory to the laptop that are designed to use genomic and computational approaches to reveal the underlying biology. In particular, we have been looking at patterns of gene expression in cancer with the goal of elucidating the networks and pathways that are fundamental in the development and progression of the disease.... Read more about John Quackenbush, PhD

Sridhar Ramaswamy, MD

HSCI Alumni: Sridhar Ramaswamy, MD

Senior VP for Research and Development, Tesaro, Inc.

Metastatic cancers are the major reason for treatment failure in the clinic, but we lack a detailed understanding of how primary tumors metastasize, why these secondary tumors are relatively drug resistant, and what enables cancer cells to remain dormant and then cause disease relapse many years after apparently curative treatment. We are taking a multidisciplinary approach to attack these fundamental and related problems. Our major goal is to identify important cancer gene networks that are essential in human cancer progression, to guide the development and clinical use of new cancer drugs and diagnostics.... Read more about Sridhar Ramaswamy, MD